2000
Predictors of inactivation and reasons for participant inactivation during a skin cancer chemoprevention study.
Cartmel B, Moon T, Levine N, Rodney S, Alberts D. Predictors of inactivation and reasons for participant inactivation during a skin cancer chemoprevention study. Cancer Epidemiology Biomarkers & Prevention 2000, 9: 999-1002. PMID: 11008922.Peer-Reviewed Original ResearchConceptsCancer chemoprevention trialsChemoprevention trialsSkin cancer chemoprevention studiesFuture chemoprevention trialsIU of retinolCancer chemoprevention studiesLow education levelSkin cancer chemoprevention trialOnly significant predictorPlacebo groupChemoprevention studiesClinical symptomsUnmarried statusCommon reasonStudy capsulesTreatment groupsInactive participantsVitamin AGood complianceFirst monthTrialsSignificant predictorsNumber of participantsSignificant differencesSymptoms
1999
Plasma Lycopene Concentrations in Humans Are Determined by Lycopene Intake, Plasma Cholesterol Concentrations and Selected Demographic Factors 1 , 2
Mayne S, Cartmel B, Silva F, Kim C, Fallon B, Briskin K, Zheng T, Baum M, Shor-Posner G, Goodwin W. Plasma Lycopene Concentrations in Humans Are Determined by Lycopene Intake, Plasma Cholesterol Concentrations and Selected Demographic Factors 1 , 2. Journal Of Nutrition 1999, 129: 849-854. PMID: 10203560, DOI: 10.1093/jn/129.4.849.Peer-Reviewed Original ResearchConceptsPlasma lycopene levelsPlasma lycopene concentrationsPlasma cholesterolLycopene levelsPlasma lycopeneLycopene intakeLycopene concentrationHigher plasma lycopene concentrationsNonwhite race/ethnicityDietary lycopene intakeCancer Prevention TrialMarital statusLow dietary intakeLower plasma cholesterolPlasma cholesterol concentrationLow plasma concentrationsLess vitamin CRace/ethnicityPrevention trialsDietary lycopeneTriglyceride levelsUnivariate analysisDietary intakeChronic diseasesPlasma concentrations